Abstract Library

#4500 Effectiveness of palbociclib plus letrozole as first line therapy of metastatic breast neuroendocrine carcinoma: A case report

Introduction: Palbociclib plus endocrine therapy is the standard treatment of advanced luminal breast cancer. However, we lack data on its effectiveness in breast neuroendocrine carcinoma (NEC).

Conference:

Presenting Author:

Authors: Saidi M, Aris H, Elyebdri H, Ilham L,

Keywords: breast neuroendocrine carcinoma, CDK4/6 inhibitor, palbociclib, endocrine therapy,

#4460 Digestive neuroendocrine tumours G1 and G2: Experience of the medical oncology department at the Oran University Hospital Establishment 1st November 1954

Introduction: The histological classification of neuroendocrine tumours (NETs) remains complex, and their grading is a major prognostic factor, essential for guiding appropriate management. Moreover, NETs raise unresolved histogenetic questions. The treatment of grade 1 (G1) NETs primarily relies on somatostatin analogues, while grade 2 (G2) NETs, being more heterogeneous, may require management that includes chemotherapy or targeted therapy.

Conference:

Presenting Author:

Authors: Kehili H, Bengueddache A, Boumansour N, Larbi Bounsbia L, Bechikh A,

Keywords: Digestive Neuroendocrine Tumour, Grade 1, Grade 2, Somatostatin Analogue,

#4444 Digestive neuroendocrine tumour diagnosis and therapeutic particularities: Experience of medical oncology centre Annaba, Algeria

Introduction: Neuroendocrine digestive tumours are increasingly diagnosed as a result of the rise in radiological and endoscopic procedures, improved pathological classification, and likely an increase in true incidence. All patient files must be discussed in RCP.

Conference:

Presenting Author:

Authors: Bechairia W, Djedi H,

Keywords: neuroendocrine digestive tumour, late diagnosis, multidisciplinary care,

#4391 Clinicopathologic characteristics, therapy and outcomes of gastroenteropancreatic neuroendocrine tumours: A single-centre experience

Introduction: Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) are tumours derived from neuroendocrine cells that can occur anywhere along the gastrointestinal tract and comprise a heterogeneous family of neoplasms with a wide and complex spectrum of clinical behaviour.

Conference:

Presenting Author:

Authors: Behourah Z, Ahed Messaoud M, Hamidatou K, Megaiz A, Lechar M,

Keywords: Gastroenteropancreatic neuroendocrine tumour, Functional neuroendocrine tumour, Somatostatin analogue (SSA), Chemotherapy,

#4365 Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the stomach: A case report

Introduction: Gastric neuroendocrine tumours (NETs) are rare neoplasms that arise from enterochromaffin cells of the gastric mucosa. Neuroendocrine carcinoma (NEC) of the stomach represent a rare and rapidly growing type of gastric tumour. They are considered a distinct entity from neuroendocrine tumours characterised by aggressive behaviour and a high rate of metastasis.

Conference:

Presenting Author: Zidane H

Authors: Zidane H, Kebbati Z, Benkada M,

Keywords: neuroendocrine carcinoma, stomach, chemotherapy,